Southeastern Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.1M | Sell |
315,285
-8,520
| -3% | -$2.06M | 3.84% | 9 |
|
|
2025
Q1 | $78.9M | Buy |
323,805
+15,336
| +5% | +$3.74M | 4.2% | 9 |
|
|
2024
Q4 | $101M | Sell |
308,469
-9,867
| -3% | -$3.24M | 4.78% | 8 |
|
|
2024
Q3 | $107M | Sell |
318,336
-6,677
| -2% | -$2.23M | 5.02% | 7 |
|
|
2024
Q2 | $88.8M | Sell |
325,013
-18,946
| -6% | -$5.17M | 3.87% | 9 |
|
|
2024
Q1 | $119M | Sell |
343,959
-20,099
| -6% | -$6.95M | 4.57% | 9 |
|
|
2023
Q4 | $118M | Buy |
364,058
+37,956
| +12% | +$12.3M | 4.52% | 8 |
|
|
2023
Q3 | $117M | Buy |
326,102
+583
| +0.2% | +$209K | 4.33% | 7 |
|
|
2023
Q2 | $123M | Buy |
+325,519
| New | +$123M | 4.35% | 8 |
|